Indiara Brusco

Indiara Brusco

Auto-generated profile, based on publicly available information

Indiara Brusco

Graduate Program in Environmental Sciences, Community University of Chapecó Region (Unochapecó), Chapecó, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2020 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
EGElaine Gonçalves
Elaine Gonçalves
GVGraziela Vieira
Graziela Vieira
TGTainara R. Gonçalves
Tainara R. Gonçalves
RSRóli R. Simões
Róli R. Simões
IBIndiara Brusco
Indiara Brusco
Rafael Cypriano DutraRafael Cypriano Dutra
Rafael Cypriano Dutra

1 March 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
GBGabriela Becker
Gabriela Becker
IBIndiara Brusco
Indiara Brusco
RCRosana Casoti
Rosana Casoti
MMMarila Crivellaro Lay Marchiori
Marila Crivellaro Lay Marchiori
Letícia CruzLetícia Cruz
Letícia Cruz
SOSara Marchesan Oliveira
Sara Marchesan Oliveira

1 September 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SKSabrina Qader Kudsi
Sabrina Qader Kudsi
CACaren Antoniazzi
Caren Antoniazzi
CCCamila Camponogara
Camila Camponogara
EBEvelyne Silva Brum
Evelyne Silva Brum
IBIndiara Brusco
Indiara Brusco
GTGabriela Trevisan
Gabriela Trevisan

11 November 2025 in Medicinal Research Reviews
Verified
Journal Article
Closed access
IBIndiara Brusco
Indiara Brusco
SOSara Marchesan Oliveira
Sara Marchesan Oliveira

3 November 2026 in Inflammopharmacology
Verified
Journal Article
Open access
PDF file
PLPatricia de Cássia Duarte Lise
Patricia de Cássia Duarte Lise
GZGabriela Adriany Lisboa Zilli
Gabriela Adriany Lisboa Zilli
HCHemyly Cardoso
Hemyly Cardoso
KBKanandra Taisa Bertoncello
Kanandra Taisa Bertoncello
GBGabriela Becker
Gabriela Becker
IBIndiara Brusco
Indiara Brusco
Fibromyalgia is a syndrome characterised by widespread chronic pain, often accompanied by comorbidities such as fatigue, anxiety, and depression. Pharmacological treatments offer only partial relief of symptoms and can cause significant adverse effects. Therefore, finding new treatments is crucial. Psychotria nemorosa , a species rich in indole alkaloids, has garnered interest due to its acute antinociceptive properties observed in vivo and its effects on monoamine oxidase A and B in in vitro assays. Additionally, alkaloids are recognised for their antinociceptive effects, as well as their anxiolytic and antidepressant properties. Therefore, we examined the effects of the alkaloid fraction of P. nemorosa in a model that simulates fibromyalgia symptoms in male Swiss. Initially, the antinociceptive effects of the fraction (3, 10, and 30 mg/kg, administered orally) were tested in capsaicin- and formalin-induced nociception, and potential adverse effects on locomotion and body temperature were evaluated. Next, the 30 mg/kg dose was tested in the reserpine-induced fibromyalgia model for mechanical, cold, and heat sensitivity, muscle strength, and behaviours resembling depression and anxiety. The P. nemorosa alkaloid fraction (30 mg/kg) decreased capsaicin- and formalin-induced nociception without affecting locomotion or body temperature. It also alleviated mechanical and cold allodynia, thermal hyperalgesia, muscle fatigue, and anxiety-like behaviour caused by reserpine, although it did not show an antidepressant-like effect. These results suggest that the P. nemorosa alkaloid fraction has therapeutic potential for treating fibromyalgia pain and related conditions such as fatigue and anxiety. They also emphasise the need for further research into its mechanisms and its long-term safety.